bioRxivCancer BiologyPreprint
A Paracrine Dietary Lipid Axis Constrains Antitumor Immunity in Liver Cancer
Nicolae CiobuiD, Reena KumariiD, Jeevotham S. KumariD, Ugne BalaseviciuteiD, Maria IftesumiD, Jonathan MitchelliD, Justin RuiziD, Sara Flowers, Kaila NishikawaiD, Guillem Cano-SegarraiD, Anna Vila-EscodaiD, Yang XiaoiD, Aiden M. PhoebeiD, Raúl NavaridasiD, Marcella SteffaniiD, Durga Prasad GannamediiD, Jenny JiniD, Bruno CogliatiiD, Michelle SaoiiD, Ritchie LyiD, Joyce Oloaigbe OgidigoiD, Monica Rodríguez-SilvaiD, Marta Pardo, Ella Pokrifka, Luis A. AlmanzaiD, , Viraj R. SanghviiD
Abstract
Overnutrition-related liver dysfunction and cancer are increasingly prevalent and highly resistant to immunotherapy. While metabolic dysregulation is a hallmark of hepatocellular carcinoma (HCC), how nutrient overload impairs antitumor immunity remains unclear. Here, we show that short-term Western diet (WD) exposure drives near-complete loss of CD8 T cell infiltration and antitumor function in HCC. We identify dietary linoleic acid (LA), the most abundant {omega}-6 fatty acid, as the dominant immunosuppressive driver. Cancer cell-restricted FADS2-mediated desaturation of LA to longer-chain {omega}-6 PUFAs drives their accumulation in the tumor interstitial fluid, suppressing infiltrating CD8 T cells via lipid peroxidation. FADS2 inhibition restores CD8 T cell function and sensitizes WD-driven HCC to PD-1-based immunotherapy. Further, the Parkinsons disease-associated deglycase DJ-1 protects LA-handling proteins from methylglyoxal-mediated glycation, sustaining tumoral immunosuppressive PUFA production. Across multiple independent human MASLD-HCC cohorts, LA metabolic activity correlates with CD8 T cell impairment, immune exclusion, and immunotherapy resistance. Overall, these studies identify a dietary lipid axis as a therapeutically actionable vulnerability in WD-associated HCC.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicity
Nicholas James Koelsch, Faridoddin Mirshahi, … Masoud H. Manjili·Liver InternationalPeer-reviewed·Apr 24, 2025
- AMPK acts to remove immune barriers to CD8+ T cell-mediated immunity against hepatocellular carcinoma
Hui-Hui Hu, Xuefeng Wang, … Sheng‐Cai Lin·Cell ResearchPeer-reviewed·Nov 25, 2025
- Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis
Sumiya Dalangood, Cegui Hu, … Jun Gui·Cell ReportsPeer-reviewed·Nov 1, 2025
- Caloric restriction alters lipid metabolism to contribute to tumor growth inhibition
E. C. Lien, A. M. Westermark, … M. Vander Heiden·bioRxiv·Mar 9, 2020
- Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas
Christian Felipe Ruiz, Xiangyu Ge, … Mandar Deepak Muzumdar·Cancer DiscoveryPeer-reviewed·Apr 29, 2026
- Blocking necroptosis reduces inflammation and tumor incidence in a mouse model of diet-induced hepatocellular carcinoma
S. Mohammed, N. Thadathil, … S. S. Deepa·bioRxiv·Aug 3, 2022